Michael B. Bottorff, PharmD: Fall risk is a major component of a discharge counseling strategy for patients who are newly being started on any anticoagulant, including a DOAC (direct oral ...

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective ...

Blood-feeding animals rely on specific molecules in their saliva to overcome defense mechanisms of their mammalian hosts for successful survival. For example, tick saliva contains molecules that can ...

Researchers from Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzyme used for clot formation) reduce the number of brain metastases (cancerous growths ...

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of warfarin, a vitamin K drug widely prescribed to prevent blood clots, is associated ...

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective ...

A study performed by researchers from the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) has discovered and synthesized several molecules ...

While the three drugs accounted for less than 10% of all anticoagulant prescriptions, they are linked to more than 90% of deaths reported to the FDA since 2010, the analysis found. The numbers are ...

Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are ...

NEW YORK, June 7, 2017 /PRNewswire/ -- Ken Research announced its latest publication on "Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to ...

Researchers have developed a system for designing protein inhibitors with reversible activity. The method is based on a supramolecular drug that results from the interaction of two or more molecules ...